Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

ARMP Armata Pharmaceuticals, Inc. Common Stock
$3.49 1.16% +0.04
Notify me if price changes either direction
Interactive Brokers Logotype

Buy ARMP stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades

Armata Pharmaceuticals, Inc. Common Stock (ARMP)

Loading

Key Stats

Market cap. 129.8M
Enterprise value 425.3M
Trailing PE -0.72083334128062
Forward PE -1.7843138
PEG Ratio 0.0013132591237906
Enterprise to EBITDA -12.717
Enterprise to revenue 76.735
Price to book MRQ -0.40806559923045
Price to sales TTM 24.416817

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-06-30
Revenue (TTM) 5.5M
EBITDA -33448000
Diluted EPS TTM -5.29
Total Cash (MRQ) 24.0M
Current ratio (MRQ) 0.109
Operating Cash Flow (TTM) -25420000

ARMP trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent ARMP News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.